from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2026c/-

LFCtreatmentdescriptionclass of inhibitor

0.069

Amikacinug/mL Amikacintranslation

0.669

Cap5-10ug/mL Capreomycintranslation

2.099

Rox10-50 ug/mL Roxithromycintranslation

0.359

SM2-5 ug/mL Streptomycintranslation

1.378

Tet5-10 ug/mL Tetracyclinetranslation

-0.482

Rif0.2-5ug/mL Rifampicintranscription

0.096

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.087

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.367

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.568

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.852

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.274

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.470

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.824

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.193

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.012

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.353

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.008

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.257

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.423

KCN5-20 ug/mL Potassium cyaniderespiration

-0.079

NaN30.2-2 mM Sodium aziderespiration

-0.186

Nigericin50 uM Nigericinrespiration

0.619

TRC10-150 ug/mL Triclosanrespiration

-1.698

TRZ10-25 ug/mL Thioridazinerespiration

0.726

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.250

menadione6-10 ug/mL Menadionerespiration

-0.603

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.206

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.365

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.333

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.267

NRP_1Non-replicating persistence stage 1dosRassociated

0.373

Amp0.2mg/mL AmpicillincellWall

-0.581

Cephalexin20-100 ug/mL CephalexincellWall

-0.113

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.174

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.679

EMB10-20 ug/mL EthambutolcellWall

0.828

Eta12-40 ug/mL EthionamidecellWall

0.397

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.010

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.155

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.039

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.898

BZA0.12 mg/mL BenzamidearomaticAmides

0.787

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.300

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.005

H2O24 mM hydrogen peroxideDNAdamaging

0.457

Levo10 ug/mL LevofloxacinDNAdamaging

0.403

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.551

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.113

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.333

UVUV-irradiationDNAdamaging

-1.236

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.276

Antimycin12.5-50 ug/mL Antimycin A?

-0.204

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.293

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.344

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.578

PA8240.2-2 ug/mL PA-824?

-0.095

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.698

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.577

Verapamil50 uM Verapamil?

-0.395

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.133

methoxatin10-20 ug/mL Methoxatin?